Mark Conley
Directeur Financier/CFO chez SAB BIOTHERAPEUTICS, INC.
Fortune : - $ au 30/06/2024
Profil
Mark Conley is currently the Chief Financial Officer at SAB Biotherapeutics, Inc. He previously worked as the Director-Global Finance at Thermo Fisher Scientific, Inc. from 2007 to 2012, the Operations Controller at Haemonetics Corp.
from 1991 to 1996, the Vice President-Financial Planning & Analysis at Iron Mountain, Inc. from 2005 to 2007, the Treasurer, Vice President & Controller at Valeritas Holdings, Inc. from 2016 to 2020, the Chief Financial Officer & Controller at HoltraChem, Inc. from 1996 to 1998, the Vice President-Finance at Kaleido Biosciences, Inc. from 2020 to 2022, and the Chief Financial Officer, Treasurer, CAO & VP at Radius Health, Inc. from 2022 to 2023.
He obtained his undergraduate degree from Oklahoma State University in 1983 and his MBA from Bryant University in 1999.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Mark Conley
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 04/06/2024 |
Anciens postes connus de Mark Conley
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Directeur Financier/CFO | 01/09/2023 |
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/03/2022 |
| VALERITAS HOLDINGS, INC. | Comptroller/Controller/Auditor | 13/01/2020 |
| THERMO FISHER SCIENTIFIC | Directeur Financier/CFO | 01/01/2012 |
| IRON MOUNTAIN INCORPORATED | Comptroller/Controller/Auditor | 01/01/2004 |
Formation de Mark Conley
| Oklahoma State University | Undergraduate Degree |
| Bryant University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| IRON MOUNTAIN INCORPORATED | Finance |
| THERMO FISHER SCIENTIFIC | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
HoltraChem, Inc.
 HoltraChem, Inc. Wholesale DistributorsDistribution Services Part of Pressure Vessel Service, Inc., HoltraChem, Inc. distributes alkalies and chlorine chemicals. The company is based in Natick, MA. HoltraChem was acquired by Pressure Vessel Service, Inc. on October 29, 1998. | Distribution Services |
